Evidence map›Paper›PMID 33587147›Full record

ArticleUrolithiasis2021

Structure and elemental composition of Ceftriaxone induced pediatric nephrolithiasis.

Yuan Du, Misun Kang, Jorge Mena, Marshall L Stoller, Sunita P Ho, Jun Li

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yuan DuDepartment of Urology, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China.ORCID http://orcid.org/0000-0002-9872-268X
Misun KangDivision of Preclinical Education, Biomaterials and Engineering, School of Dentistry, University of California, 707 Parnassus Avenue, D 3212, San Francisco, CA, 94143, USA.
Jorge MenaDepartment of Urology, School of Medicine, University of California, 400 Parnassus Avenue, San Francisco, CA, 94143-0330, USA.
Marshall L StollerDepartment of Urology, School of Medicine, University of California, 400 Parnassus Avenue, San Francisco, CA, 94143-0330, USA. Marshall.Stoller@ucsf.edu.
Sunita P HoDivision of Preclinical Education, Biomaterials and Engineering, School of Dentistry, University of California, 707 Parnassus Avenue, D 3212, San Francisco, CA, 94143, USA. Sunita.Ho@ucsf.edu.
Jun LiDepartment of Urology, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China. lljun@yeah.net.
University of California, San Francisco · USCapital Medical University · CN

Funding

Research Foundation of Beijing Friendship Hospital, Capital Medical University yyqdkt2019-38
6 · The paper itself

Abstract

Ceftriaxone is a widely used antibiotic because to its broad-spectrum gram-negative coverage, safety, and biological half life (5-9 h) permit dose once-daily administration. It is specifically used in pediatric patients in developing countries. Ceftriaxone forms insoluble sludge/stone when combined with calcium in the urinary system. In this study, Ceftriaxone induced sludge/stones from pediatric patients were collected to identify its microstructure and composition to gather insights into the mechanism of Ceftriaxone induced sludge/stone formation. The results illustrated that Ceftriaxone induced stones formed rapidly following antibiotic administration. Ceftriaxone calcium salt crystals could easily be broken with minimal intervention. However, Ceftriaxone combined with calcium phosphate formed an insoluble stone aggregate.

Indexed as

AdolescentAnti-Bacterial AgentsCeftriaxoneChildChild, PreschoolFemaleHumansInfantMaleNephrolithiasisAnti-Bacterial AgentsCeftriaxoneCalculusCeftriaxoneKidneyNephrolithiasesPediatric

Identifiers

PMID33587147
OpenAlexW3130919156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.